These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 30418112

  • 1. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?
    Erden A, Batu ED, Sarı A, Sönmez HE, Armagan B, Demir S, Fırat E, Bilginer Y, Bilgen SA, Karadağ Ö, Kalyoncu U, Kiraz S, Ertenli I, Özen S, Akdogan A.
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):97-102. PubMed ID: 30418112
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T, Sato S, Miyamoto J, Hagimori N, Kawazoe Y, Arinaga K, Fukushima C, Yamamoto H, Kawakami A.
    Trials; 2018 Dec 29; 19(1):715. PubMed ID: 30594222
    [Abstract] [Full Text] [Related]

  • 3. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T, Aydın F, Nilüfer Tekgöz P, Sezer M, Uncu N, Çelikel Acar B.
    Int J Rheum Dis; 2020 Jul 29; 23(7):977-981. PubMed ID: 32558310
    [Abstract] [Full Text] [Related]

  • 4. Familial Mediterranean fever in childhood: a single-center experience.
    Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G, Pamuk G, Aydın AK, Dasdemir S, Turanlı ET, Buyru N, Kasapcopur O.
    Rheumatol Int; 2018 Jan 29; 38(1):67-74. PubMed ID: 28828621
    [Abstract] [Full Text] [Related]

  • 5. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB, Özdel S, Yılmaz S, Kurt-Şükür ED, Ekim M, Yalçınkaya F.
    Clin Rheumatol; 2016 Feb 29; 35(2):441-6. PubMed ID: 25213327
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö, Kucuk H, Babaoglu H, Guven SC, Ozturk MA, Haznedaroglu S, Goker B, Tufan A.
    Mod Rheumatol; 2019 Mar 29; 29(2):363-366. PubMed ID: 29578360
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever.
    Alpay N, Sumnu A, Calışkan Y, Yazıcı H, Türkmen A, Gül A.
    Rheumatol Int; 2012 Oct 29; 32(10):3277-9. PubMed ID: 20386914
    [Abstract] [Full Text] [Related]

  • 8. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S.
    Rheumatol Int; 2015 Oct 29; 35(10):1733-7. PubMed ID: 26001859
    [Abstract] [Full Text] [Related]

  • 9. Canakinumab treatment in children with familial Mediterranean fever: report from a single center.
    Yazılıtaş F, Aydoğ Ö, Özlü SG, Çakıcı EK, Güngör T, Eroğlu FK, Gür G, Bülbül M.
    Rheumatol Int; 2018 May 29; 38(5):879-885. PubMed ID: 29450637
    [Abstract] [Full Text] [Related]

  • 10. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G, Kose R, Senturk T.
    Sao Paulo Med J; 2019 May 08; 137(1):39-44. PubMed ID: 31116269
    [Abstract] [Full Text] [Related]

  • 11. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.
    Hentgen V, Vinit C, Fayand A, Georgin-Lavialle S.
    Front Immunol; 2020 May 08; 11():971. PubMed ID: 32670263
    [Abstract] [Full Text] [Related]

  • 12. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
    Corsia A, Georgin-Lavialle S, Hentgen V, Hachulla E, Grateau G, Faye A, Quartier P, Rossi-Semerano L, Koné-Paut I.
    Orphanet J Rare Dis; 2017 Mar 16; 12(1):54. PubMed ID: 28302131
    [Abstract] [Full Text] [Related]

  • 13. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
    Bilgen SA, Kilic L, Akdogan A, Kiraz S, Kalyoncu U, Karadag O, Ertenli I, Dogan I, Calguneri M.
    J Clin Rheumatol; 2011 Oct 16; 17(7):358-62. PubMed ID: 21946459
    [Abstract] [Full Text] [Related]

  • 14. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
    Sozeri B, Kasapcopur O.
    Curr Med Chem; 2015 Oct 16; 22(16):1986-91. PubMed ID: 25760087
    [Abstract] [Full Text] [Related]

  • 15. [Familial Mediterranean fever: not to be missed].
    Frenkel J, Bemelman FJ, Potter van Loon BJ, Simon A.
    Ned Tijdschr Geneeskd; 2013 Oct 16; 157(18):A5784. PubMed ID: 23635502
    [Abstract] [Full Text] [Related]

  • 16. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
    Omma A, Sandikci SC, Kücüksahin O, Alisik M, Erel O.
    J Korean Med Sci; 2017 Oct 16; 32(10):1588-1594. PubMed ID: 28875601
    [Abstract] [Full Text] [Related]

  • 17. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A, Derin ME, Albayrak F, Karakaş B, Karagöz Y.
    Adv Rheumatol; 2020 Jan 30; 60(1):12. PubMed ID: 32000860
    [Abstract] [Full Text] [Related]

  • 18. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.
    Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, Barron KS, Weisman MH, Pashinian N, Reiff AO, Samuels J, Wright DA, Kastner DL, Lovell DJ.
    Ann Intern Med; 2012 Oct 16; 157(8):533-41. PubMed ID: 23070486
    [Abstract] [Full Text] [Related]

  • 19. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S, Dogantan S, Edeer Karaca N, Aksu G, Kutukculer N.
    Rheumatol Int; 2020 Jan 16; 40(1):161-168. PubMed ID: 31273456
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic approach to patients with familial Mediterranean fever-related amyloidosis resistant to colchicine.
    Korkmaz C.
    Clin Exp Rheumatol; 2012 Jan 16; 30(3 Suppl 72):S104-7. PubMed ID: 23010471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.